Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer

被引:0
|
作者
Chun Huang
Xuan Wang
Baocun Sun
Man Li
Xiulan Zhao
Yanjun Gu
Yanfen Cui
Yan Li
机构
[1] Tianjin Medical University Cancer Institute and Hospital,Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Department of Medical Oncology
[2] National Clinical Research Center of Cancer,Department of Nutrition and Food Science, School of Public Health
[3] Tianjin Medical University,Department of Pathology
[4] Tianjin Cancer Institute and Hospital,Department of Pathology
[5] Tianjin Medical University,Department of Digestive
[6] The Second Hospital of Tianjin Medical University,Department of Pathology
[7] Medical College of the Chinese People’s Armed Police Forces,undefined
来源
Targeted Oncology | 2015年 / 10卷
关键词
Spontaneous breast cancer; Triple-negative phenotype of breast cancer; TA2 mice; Pregnancy;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate the association between high parity and triple-negative breast cancer (TNBC), and explore the etiologic mechanisms of TNBC in Tientsin Albinao 2 (TA2) mice model. After the TA2 mice model with high parity and TNBC had been established, the cell proliferation and apoptosis were detected by immunohistochemical and TUNEL staining in mammary epithelia from different conditions, which included non-pregnancy, low and high gravidity in pregnancy, and carcinogenesis. Apoptotic signaling was analyzed by measuring bcl-2, bax, caspase-3, and caspase-9 expression using immunohistochemistry (IHC), western blot, and real-time PCR technique. Estrogen receptor α (ERα) and progesterone receptor (PR) were determined by immunohistochemical staining and real-time PCR. Both proliferation and apoptosis in mammary epithelia changed with the increasing of parity. Immunohistochemistry revealed increased cell proliferation and apoptosis were related with upregulation of ERα, PR, bcl-2, bax, caspase-3, and caspase-9 expression, especially during the fourth pregnancy. Mammary gland in the fourth pregnancy stage was the closest to precancerous. In precancerous mammary gland, cell proliferation rate was much higher than apoptosis rate. High parity could increase the ovarian hormones level and alter ovarian hormone receptor levels in TA2 mice, and their sensitivity to ovarian hormones result in the imbalance between cell proliferation and apoptosis in precancerous mammary epithelial cells.
引用
收藏
页码:85 / 97
页数:12
相关论文
共 50 条
  • [1] Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer
    Huang, Chun
    Wang, Xuan
    Sun, Baocun
    Li, Man
    Zhao, Xiulan
    Gu, Yanjun
    Cui, Yanfen
    Li, Yan
    TARGETED ONCOLOGY, 2015, 10 (01) : 85 - 97
  • [2] Triple-Negative Breast Cancer
    Winkeljohn, Debra L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (06) : 861 - 863
  • [3] Triple-Negative Breast Cancer
    Hudis, Clifford A.
    CANCER JOURNAL, 2010, 16 (01): : 10 - 11
  • [4] Triple-negative breast cancer
    Chacon, Reinaldo D.
    Costanzo, Maria V.
    BREAST CANCER RESEARCH, 2010, 12
  • [5] Triple-Negative Breast Cancer
    Quyen D. Chu
    King, Tari
    Hurd, Thelma
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
  • [6] Triple-negative breast cancer
    Stockmans, Gert
    Deraedt, Karen
    Wildiers, Hans
    Moerman, Philippe
    Paridaens, Robert
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 614 - 620
  • [7] Triple-Negative Breast Cancer
    Foulkes, William D.
    Smith, Ian E.
    Reis-Filho, Jorge S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20): : 1938 - 1948
  • [8] Triple-negative breast cancer
    Bartsch R.
    Ziebermayr R.
    Zielinski C.C.
    Steger G.G.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 174 - 181
  • [9] Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Schmutzler, Rita
    Schneeweiss, Andreas
    Loibl, Sybille
    Thill, Marc
    Heitz, Florian
    BREAST CARE, 2010, 5 (05) : 359 - 363
  • [10] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12